ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

This adverse event was reported 6823 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE:

# Drug Count
0 METHOTREXATE SODIUM 5969
1 LEFLUNOMIDE 5968
2 ADALIMUMAB 5869
3 TOCILIZUMAB 5824
4 METHOTREXATE 5675
5 RITUXIMAB 5602
6 INFLIXIMAB 5577
7 PREDNISONE 5516
8 CERTOLIZUMAB PEGOL 5506
9 SULFASALAZINE 5485
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CAFFEINE CITRATE 896 0.4108
1 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 234 0.3855
2 CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL 102 0.3400
3 PSEUDOEPHEDRINE HCL 3515 0.3305
4 CORTISONE ACETATE 3833 0.3186
5 DESOXIMETASONE 5327 0.2873
6 USTEKINUMAB-AEKN 1 0.2500
7 TRIPROLIDINE HYDROCHLORIDE 40 0.2273
8 HYDROCORTISONE BUTYRATE 400 0.2176
9 DICLOFENAC POTASSIUM TABLETS 1647 0.2059
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antirheumatic Agent [EPC] 5968 0.0575
1 Interleukin-6 Receptor Antagonist [EPC] 5938 0.0449
2 Aminosalicylate [EPC] 5531 0.0425
3 Selective T Cell Costimulation Modulator [EPC] 5347 0.0395
4 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 693 0.0362
5 Interleukin-12 Antagonist [EPC] 3504 0.0348
6 Histamine-1 Receptor Antagonist [EPC] 2565 0.0318
7 Endoglycosidase [EPC] 226 0.0237
8 Vitamin D [EPC] 5460 0.0184
9 Vitamin B12 [EPC] 5514 0.0174
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE